Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $33,863 | 20 | 43.4% |
| Consulting Fee | $15,601 | 6 | 20.0% |
| Unspecified | $10,240 | 20 | 13.1% |
| Travel and Lodging | $9,622 | 49 | 12.3% |
| Food and Beverage | $8,715 | 338 | 11.2% |
| Education | $6.02 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $28,265 | 69 | $0 (2023) |
| Novo Nordisk Inc | $15,164 | 90 | $0 (2024) |
| GlaxoSmithKline, LLC. | $14,815 | 42 | $0 (2021) |
| Eli Lilly and Company | $9,706 | 9 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $2,268 | 42 | $0 (2024) |
| Novo Nordisk AS | $1,506 | 4 | $0 (2017) |
| Boehringer Ingelheim International GmbH | $1,459 | 12 | $0 (2023) |
| Kowa Research Institute, Inc. | $1,152 | 11 | $0 (2017) |
| Chiesi USA, Inc. | $772.01 | 2 | $0 (2023) |
| Amgen Inc. | $498.73 | 30 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,884 | 21 | AstraZeneca Pharmaceuticals LP ($1,740) |
| 2023 | $3,159 | 46 | Boehringer Ingelheim International GmbH ($1,459) |
| 2022 | $887.72 | 37 | Novo Nordisk Inc ($170.69) |
| 2021 | $1,997 | 27 | Novo Nordisk Inc ($1,721) |
| 2020 | $9,936 | 29 | Novo Nordisk Inc ($7,539) |
| 2019 | $11,654 | 73 | Novo Nordisk Inc ($5,256) |
| 2018 | $17,415 | 84 | Eli Lilly and Company ($6,141) |
| 2017 | $31,113 | 117 | Janssen Pharmaceuticals, Inc ($21,364) |
All Payment Transactions
434 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | In-kind items and services | $560.88 | General |
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | In-kind items and services | $261.06 | General |
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | In-kind items and services | $261.06 | General |
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $135.00 | General |
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 06/25/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: SURGERY | ||||||
| 06/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $48.41 | General |
| 03/21/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 03/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: VACCINES | ||||||
| 03/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.05 | General |
| 02/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $126.14 | General |
| 01/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: Respiratory | ||||||
| 01/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Diabetes | ||||||
| 11/27/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Diabetes | ||||||
| 11/22/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Diabetes Care | ||||||
| 11/22/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: VACCINES | ||||||
| 11/15/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PARALLEL ARM STUDY OF THE EFFICACY AND SAFETY OF INVESTIGATIONAL DULAGLUTIDE DOSES WHEN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | Eli Lilly and Company | $8,366 | 4 |
| A Clinical Outcomes Study to compare the effect of Fluticasone Furoate Vilanterol Inhalation Powder 100 25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease COPD and a history of or at increased risk for cardiov | GlaxoSmithKline, LLC. | $725.82 | 6 |
| A PHASE III, 52 WEEK, RANDOMIZED, DOUBLE BLIND, 3-ARM PARALLEL GROUP S | GlaxoSmithKline, LLC. | $705.62 | 9 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,072 | 1,551 | $321,735 | $103,881 |
| 2022 | 17 | 1,133 | 1,654 | $329,520 | $114,232 |
| 2021 | 23 | 1,234 | 1,820 | $361,577 | $123,731 |
| 2020 | 17 | 1,139 | 1,578 | $317,705 | $96,928 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 289 | 536 | $105,592 | $40,675 | 38.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 242 | 242 | $75,504 | $29,539 | 39.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 87 | 133 | $47,570 | $7,977 | 16.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 81 | 98 | $13,034 | $5,786 | 44.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 45 | 59 | $31,398 | $5,327 | 17.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 41 | $10,865 | $5,212 | 48.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 35 | 35 | $6,405 | $2,653 | 41.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $5,136 | $1,879 | 36.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 20 | 20 | $11,048 | $1,731 | 15.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 40 | 40 | $2,680 | $1,138 | 42.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 55 | 58 | $4,930 | $882.25 | 17.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 38 | 89 | $5,963 | $793.38 | 13.3% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 20 | 20 | $500.00 | $156.02 | 31.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 31 | 50 | $500.00 | $110.00 | 22.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 18 | 41 | $533.00 | $16.46 | 3.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 20 | 77 | $77.00 | $6.33 | 8.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 301 | 588 | $115,836 | $46,794 | 40.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 231 | 231 | $72,072 | $28,734 | 39.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 147 | 234 | $78,858 | $18,104 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 91 | $12,103 | $4,801 | 39.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 35 | $9,275 | $4,240 | 45.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 50 | 51 | $9,333 | $3,567 | 38.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 28 | 28 | $9,184 | $2,205 | 24.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $5,136 | $1,895 | 36.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 53 | 54 | $3,618 | $1,468 | 40.6% |
About Dr. Eugene Ryan, MD
Dr. Eugene Ryan, MD is a Internal Medicine healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609865088.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eugene Ryan, MD has received a total of $78,046 in payments from pharmaceutical and medical device companies, with $1,884 received in 2024. These payments were reported across 434 transactions from 49 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($33,863).
As a Medicare-enrolled provider, Ryan has provided services to 4,578 Medicare beneficiaries, totaling 6,603 services with total Medicare billing of $438,773. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Chattanooga, TN
- Active Since 10/18/2005
- Last Updated 02/10/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1609865088
Products in Payments
- INVOKANA (Drug) $28,163
- TRULICITY (Drug) $9,742
- RYBELSUS (Drug) $5,324
- Ozempic (Drug) $4,550
- Victoza (Drug) $4,094
- TRELEGY ELLIPTA (Drug) $2,190
- Tresiba (Drug) $1,593
- FARXIGA (Drug) $319.24
- SOLIQUA (Drug) $183.94
- TOUJEO (Drug) $168.19
- Repatha (Biological) $153.04
- NEXLETOL (Drug) $150.35
- Kerendia (Drug) $146.99
- EVENITY (Biological) $143.15
- PREVNAR 20 (Biological) $104.86
- Aimovig (Biological) $99.71
- Prolia (Biological) $80.03
- JARDIANCE (Drug) $71.25
- Rybelsus (Drug) $70.49
- ACTHAR (Biological) $68.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Chattanooga
Dr. Krishnendu Bhadra, Md, MD
Internal Medicine — Payments: $423,314
Dr. Michael Czarnecki, Md, MD
Internal Medicine — Payments: $417,472
Selcuk Tombul, Do, DO
Internal Medicine — Payments: $317,513
Mark Mckenzie, Md, MD
Internal Medicine — Payments: $217,376
Dr. Matthew Wiisanen, Md, MD
Internal Medicine — Payments: $140,499
Dr. Maighan Seagrove, D.o, D.O
Internal Medicine — Payments: $64,768